Hjem › Overvægt › Texas › Amarillo
Overvægt kliniske forsøg i Amarillo, TX
10 studier for Overvægt søger deltagere på steder i og omkring Amarillo (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 2
- Amarillo Medical Specialists /ID# 282380, Amarillo
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RekruttererFase 3
- Amarillo Medical Specialists, Amarillo
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RekruttererFase 3
- Amarillo Med Spec LLP, Amarillo
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
RekruttererFase 3
- Amarillo Medical Specialists, Amarillo
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekruttererFase 3
- PharmaTex Research, LLC, Amarillo
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruttererFase 3
- PharmaTex Research, LLC, Amarillo
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RekruttererFase 3
- Kailera Clinical Site, Amarillo
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RekruttererFase 3
- Kailera Clinical Site, Amarillo
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruttererFase 3
- PharmaTex Research, LLC, Amarillo
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
RekruttererFase 1
- Amarillo Medical Specialists, Amarillo
Overvægt forsøg i andre byer
- Houston, TX43 studier
- Chicago, IL41 studier
- New York City, NY40 studier
- San Antonio, TX40 studier
- Washington, DC33 studier
- Orlando, FL31 studier
- Dallas, TX30 studier
- Boston, MA28 studier
- Las Vegas, NV27 studier
- Miami, FL27 studier
- Baltimore, MD25 studier
- Jacksonville, FL25 studier
Andre studier i Amarillo
- Hjertesvigt8 studier
- Ikke-småcellet lungecancer8 studier
- Overvægt7 studier
- Aterosklerose6 studier
- Lungecancer5 studier
- Kardiovaskulær sygdom5 studier
- Blodpropper4 studier
- Atrieflimmer3 studier
- Fordøjelsessygdomme3 studier
- Colorektal kræft3 studier
- Brystkræft3 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.